ENvue Medical, Inc. announced a reverse stock split of its common stock at a ratio of 1-for-12, effective September 1, 2026. The transaction was approved by the board and stockholders on August 14, 2026, and implemented via a Certificate of Amendment filed with Delaware on August 28, 2026. Outstanding shares will decrease from approximately 11,084,616 to roughly 923,718, with fractional shares rounded up to the nearest whole share rather than cashed out. The trading symbol remains FEED on Nasdaq, though a new CUSIP number applies. ENvue Medical is a medical technology company specializing in non-invasive enteral care solutions and acoustic-based therapeutic devices.
